Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Annals of Nuclear Medicine|April 26, 2025
Comparison and cutoff values of two amyloid PET scaling methods: centiloid scale and amyloid-β loadRyo Yamakuni, Mitsunari Abe, Naoyuki Ukon, et al.
Frontiers in Aging Neuroscience|August 4, 2018
Dissociation of Tau Deposits and Brain Atrophy in Early Alzheimer's Disease: A Combined Positron Emission Tomography/Magnetic Resonance Imaging StudyYoko Shigemoto, Daichi Sone, Etsuko Imabayashi, et al.
Neuropsychopharmacology Reports|February 13, 2024
Longitudinal reduction in brain volume in patients with schizophrenia and its association with cognitive functionRyuichi Yamazaki, Junya Matsumoto, Satsuki Ito, et al.
The International Journal of Neuropsychopharmacology|October 11, 2017
Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2Sho Moriguchi, Harumasa Takano, Yasuyuki Kimura, et al.
Schizophrenia Research|December 6, 2008
Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PETShoko Nozaki, Motoichiro Kato, Harumasa Takano, et al.
Aging Clinical and Experimental Research|July 20, 2021
Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairmentWataru Araki, Kazutomi Kanemaru, Kotaro Hattori, et al.
Translational Psychiatry|February 19, 2026
Gray and White matter microstructural alterations in major depressive disorder: a multi-center diffusion imaging studyKento Takahashi, Taro Suwa, Yujiro Yoshihara, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 25, 2004
Cerebral white matter blood flow is constant during human non-rapid eye movement sleep: a positron emission tomographic studyMasahiko Hiroki, Takeshi Uema, Naofumi Kajimura, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brainTatsui Otsuka, Hiroshi Ito, Christer Halldin, et al.
Pageof 10